396 related articles for article (PubMed ID: 24495273)
1. Taste-masked and affordable donepezil hydrochloride orally disintegrating tablet as promising solution for non-compliance in Alzheimer's disease patients.
Liew KB; Tan YT; Peh KK
Drug Dev Ind Pharm; 2015 Apr; 41(4):583-93. PubMed ID: 24495273
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex.
Kim JI; Cho SM; Cui JH; Cao QR; Oh E; Lee BJ
Int J Pharm; 2013 Oct; 455(1-2):31-9. PubMed ID: 23933050
[TBL] [Abstract][Full Text] [Related]
3. Effect of polymer, plasticizer and filler on orally disintegrating film.
Liew KB; Tan YT; Peh KK
Drug Dev Ind Pharm; 2014 Jan; 40(1):110-9. PubMed ID: 23311593
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of taste-masked donepezil hydrochloride orally disintegrating tablets.
Yan YD; Woo JS; Kang JH; Yong CS; Choi HG
Biol Pharm Bull; 2010; 33(8):1364-70. PubMed ID: 20686233
[TBL] [Abstract][Full Text] [Related]
5. Formulation and in vivo evaluation of ondansetron orally disintegrating tablets using different superdisintegrants.
Sheshala R; Khan N; Chitneni M; Darwis Y
Arch Pharm Res; 2011 Nov; 34(11):1945-56. PubMed ID: 22139694
[TBL] [Abstract][Full Text] [Related]
6. Characterization of oral disintegrating film containing donepezil for Alzheimer disease.
Liew KB; Tan YT; Peh KK
AAPS PharmSciTech; 2012 Mar; 13(1):134-42. PubMed ID: 22167416
[TBL] [Abstract][Full Text] [Related]
7. Formulation, preparation, and evaluation of novel orally disintegrating tablets containing taste-masked naproxen sodium granules and naratriptan hydrochloride.
Stange U; Führling C; Gieseler H
J Pharm Sci; 2014 Apr; 103(4):1233-45. PubMed ID: 24532095
[TBL] [Abstract][Full Text] [Related]
8. Formulation studies for mirtazapine orally disintegrating tablets.
Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Ünlü N
Drug Dev Ind Pharm; 2016; 42(6):1008-17. PubMed ID: 26530146
[TBL] [Abstract][Full Text] [Related]
9. Formulation and in vitro evaluation of ketoprofen fast-dissolving tablets.
Comoglu T; Inal O; Yaacoub HB
Pharm Dev Technol; 2016 Dec; 21(8):901-908. PubMed ID: 25798913
[TBL] [Abstract][Full Text] [Related]
10. Design, development and in-vitro evaluation of diclofenac taste-masked orodispersible tablet formulations.
Guhmann M; Preis M; Gerber F; Pöllinger N; Breitkreutz J; Weitschies W
Drug Dev Ind Pharm; 2015 Apr; 41(4):540-51. PubMed ID: 24495274
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of different approaches for preparation of chlorzoxazone orodispersible tablets.
Moqbel HA; ElMeshad AN; El-Nabarawi MA
Drug Dev Ind Pharm; 2017 May; 43(5):742-750. PubMed ID: 27534668
[TBL] [Abstract][Full Text] [Related]
12. Formulation and optimization of orally disintegrating tablets of sumatriptan succinate.
Sheshala R; Khan N; Darwis Y
Chem Pharm Bull (Tokyo); 2011; 59(8):920-8. PubMed ID: 21804234
[TBL] [Abstract][Full Text] [Related]
13. A novel and discriminative method of in vitro disintegration time for preparation and optimization of taste-masked orally disintegrating tablets of carbinoxamine maleate.
Liu Y; Li P; Qian R; Sun T; Fang F; Wang Z; Ke X; Xu B
Drug Dev Ind Pharm; 2018 Aug; 44(8):1317-1327. PubMed ID: 29521132
[TBL] [Abstract][Full Text] [Related]
14. [Orally disintegrating donepezil: are the main caregivers of patients with Alzheimer's disease more satisfied with this formulation of donepezil than with the traditional one?].
Sevilla C; Jiménez-Caballero PE; Alfonso V
Rev Neurol; 2009 Nov 1-15; 49(9):451-7. PubMed ID: 19859884
[TBL] [Abstract][Full Text] [Related]
15. Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression.
Tafere C; Yilma Z; Abrha S; Yehualaw A
PLoS One; 2021; 16(3):e0246648. PubMed ID: 33725014
[TBL] [Abstract][Full Text] [Related]
16. Preparation and evaluation of orally disintegrating tablets of taste masked phencynonate HCl using ion-exchange resin.
Ge Z; Yang M; Wang Y; Shan L; Gao C
Drug Dev Ind Pharm; 2015 Jun; 41(6):934-41. PubMed ID: 24785576
[TBL] [Abstract][Full Text] [Related]
17. Effect of processing methods on xylitol-starch base co-processed adjuvant for orally disintegrating tablet application.
Bin LK; Helaluddin ABM; Islam Sarker MZ; Mandal UK; Gaurav A
Pak J Pharm Sci; 2020 Mar; 33(2):551-559. PubMed ID: 32276897
[TBL] [Abstract][Full Text] [Related]
18. Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets.
Douroumis DD; Gryczke A; Schminke S
AAPS PharmSciTech; 2011 Mar; 12(1):141-51. PubMed ID: 21181510
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of orally disintegrating tablets comprising taste-masked mirtazapine granules.
Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Vural İ; Ünlü N
Pharm Dev Technol; 2018 Jun; 23(5):488-495. PubMed ID: 28368673
[TBL] [Abstract][Full Text] [Related]
20. A dual strategy to improve psychotic patients' compliance using sustained release quetiapine oral disintegrating tablets.
Refaat A; Sokar M; Ismail F; Boraei N
Acta Pharm; 2016 Dec; 66(4):515-532. PubMed ID: 27749256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]